Tag Archives: Stem Cell Therapy for Parkinson’s disease

Researchers at Kyoto University recently conducted a Phase I/II clinical trial to evaluate the safety and potential side effects of stem cell therapy using dopaminergic progenitors derived from human-induced pluripotent stem cells (iPSCs). About Parkinson’s Disease Parkinson’s disease is a neurodegenerative condition characterized by the gradual loss of dopamine-producing neurons …

Read More »